Regresa al Registro Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorBudde, Lihua
dc.contributor.authorAssouline, Sarit
dc.contributor.authorSehn, Laurie
dc.contributor.authorSchuster, Stephen
dc.contributor.authorYoon, Sung-Soo
dc.contributor.authorYoon, Dok Hyun
dc.contributor.authorBosch Albareda, Francesc
dc.date.accessioned2023-04-18T12:10:42Z
dc.date.available2023-04-18T12:10:42Z
dc.date.issued2022-02-10
dc.identifier.citationBudde LE, Assouline S, Sehn LH, Schuster SJ, Yoon SS, Yoon DH, et al. Single-Agent Mosunetuzumab Shows Durable Complete Responses in Patients with Relapsed or Refractory B-Cell Lymphomas: Phase I Dose-Escalation Study. J Clin Oncol. 2022 Feb 10;40(5):481–91.
dc.identifier.issn1527-7755
dc.identifier.urihttps://hdl.handle.net/11351/9359
dc.descriptionMosunetuzumab; Linfomas de células b
dc.language.isoeng
dc.publisherAmerican Society of Clinical Oncology
dc.relation.ispartofseriesJournal of Clinical Oncology;40(5)
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceScientia
dc.subjectCèl·lules B - Tumors - Immunoteràpia
dc.subjectAvaluació de resultats (Assistència sanitària)
dc.subjectPosologia
dc.subject.meshLymphoma, B-Cell
dc.subject.mesh/drug therapy
dc.subject.meshAntineoplastic Agents, Immunological
dc.subject.mesh/administration & dosage
dc.subject.meshTreatment Outcome
dc.titleSingle-Agent Mosunetuzumab Shows Durable Complete Responses in Patients With Relapsed or Refractory B-Cell Lymphomas: Phase I Dose-Escalation Study
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1200/JCO.21.00931
dc.subject.decslinfoma de células B
dc.subject.decs/farmacoterapia
dc.subject.decsinmunoterapia antineoplásica
dc.subject.decs/administración & dosificación
dc.subject.decsresultado del tratamiento
dc.relation.publishversionhttps://doi.org/10.1200/JCO.21.00931
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Budde LE] City of Hope National Medical Center, Duarte, CA. [Assouline S] Jewish General Hospital and McGill University, Montreal, Quebec, Canada. [Sehn LH] BC Cancer Centre for Lymphoid Cancer and The University of British Columbia, Vancouver, British Columbia, Canada. [Schuster SJ] Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA. [Yoon SS] Seoul National University Hospital, Seoul, South Korea. [Yoon DH] Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. [Bosch F] Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
dc.identifier.pmid34914545
dc.identifier.wos000819042300006
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Regresa al Registro Simple